CORC

在结果中检索

CORC

浏览/检索结果: 共13条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Poly (vinyl butyral)/Graphene oxide/poly (methylhydrosiloxane) nanocomposite coating for improved aluminum alloy anticorrosion 期刊论文
POLYMER, 2019, 卷号: 172, 页码: 415-422
作者:  Zhu, Guiyu;  Cui, Xiaokun;  Zhang, Yue;  Chen, Shougang;  Dong, Mengyao
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/11
Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study 期刊论文
2019, 卷号: 10, 期号: 6, 页码: 1431-1440
作者:  Ni, Wenjie;  Chen, Junqiang;  Xiao, Zefen;  Yu, Shufei;  Zhang, Wencheng
收藏  |  浏览/下载：26/0  |  提交时间：2020/01/03
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy 期刊论文
2019, 卷号: 26, 期号: 9, 页码: 2890-2898
作者:  Deng, Wei;  Zhang, Wencheng;  Yang, Jinsong;  Ni, Wenjie;  Yu, Shufei
收藏  |  浏览/下载：25/0  |  提交时间：2020/01/03
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study 期刊论文
LANCET DIABETES & ENDOCRINOLOGY, 2018, 卷号: 6, 期号: 8
作者:  Zhao, Guiyu;  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study 期刊论文
LANCET DIABETES & ENDOCRINOLOGY, 2018, 卷号: 6, 期号: 8
作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study 期刊论文
The Lancet Diabetes and Endocrinology, 2018, 卷号: 6, 期号: 8, 页码: 627-636
作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/03
Polydimethylsiloxane-titania nanocomposite coating: Fabrication and corrosion resistance 期刊论文
POLYMER, 2018, 卷号: 138, 页码: 203-210
作者:  Cui, Xiaokun;  Zhu, Guiyu;  Pan, Yufeng;  Shao, Qian;  Zhao, Cindy
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/11
Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 期刊论文
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 卷号: 33
作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 期刊论文
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 卷号: 33
作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 会议论文
作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace